Log In
Print
BCIQ
Print
Print this Print this
 

Alpharen, Replidea (CTAP101)

  Manage Alerts
Collapse Summary General Information
Company Opko Health Inc.
DescriptionModified-release formulation of 25-hydroxyvitamin D
Molecular Target
Mechanism of Action 
 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of Development
More More
 Archive Items are loading loading
Get a free BioCentury trial today